Demographics
| |
Age, years
|
61 (53–69)
|
Sex, male
|
98 (61)
|
Body mass index, kg/m2
|
26 (24–31)
|
Comorbidities
| |
Cardiovascular disease
|
75 (47)
|
Chronic kidney disease
|
13 (8)
|
COPD
|
17 (11)
|
Diabetes
|
40 (25)
|
Immune deficiency
|
12 (7)
|
Chronic liver disease
|
9 (6)
|
Malignancy
|
14 (9)
|
Peripheral vascular disease
|
21 (13)
|
Rheumatoid disease
|
11 (7)
|
No comorbidities
|
49 (30)
|
Pre-existing conditions
| |
Active smokera
|
49 (30)
|
High alcohol consumptionb
|
23 (14)
|
Steroid treatment
|
21 (13)
|
Immunosuppressing drugs
|
15 (9)
|
Biochemistry
| |
Leukocyte count, 109/L
|
16.2 (11.4–22.7)
|
C-reactive protein, mg/L
|
224 (153–309)
|
Procalcitonin, µg/L
|
8.6 (2.1–37.1)
|
Creatinine, µmol/L
|
121 (79–307)
|
Lactate, mmol/L
|
2.3 (1.3–4.7)
|
Other
| |
SOFA scorec
|
8 (6–11)
|
SAPS IId
|
45 (35–54)
|
Septic shocke
|
80 (50)
|
ICU length of stay, daysf
|
7 (4–13)
|
Amputation within 7 daysg
|
27 (17)
|
RRT within 7 days
|
35 (22)
|
30-day mortality, n (%, 95% CI)
|
28 (17, 12–24)
|
90-day mortality, n (%, 95% CI)
|
37 (23, 17–30)
|